...Maya Zlotnick; Abraham Avigdor; Elena Ribakovsky; Arnon Nagler; Meirav Kedmi Gemcitabine-based salvage therapy is considered an effective treatment for relapsed and refractory Non-Hodgkin’s lymphoma (NHL). We analyzed the outcome of 41 consecutive NHL patients treated with gemcitabine-based...

... cell lymphoma entities is unknown. To answer this open question in Austria, we screened the Tyrolean registry for B cell non-Hodgkin's lymphomas regarding primary and secondary lung involvement. Of 854 patients affected by B cell lymphoma, 7.5% had lung/pleural disease. This organ was the primary site...

... within this age span. Non-Hodgkin's lymphoma (NHL) comprises approximately 7% of cancer among AYAs, and patient allocation and therapy vary between health systems. In this systematic review we focus on the current biological and clinical knowledge relevant to AYAs with NHL applying these data...

...Keiko Morikawa; Takahiro Tsuji; Hiroshi Yamasaki; Yasuo Toyozumi; Nobuyuki Arima; Koichi Ohshima; Hiroyuki Tsuda Recurrence of non-Hodgkin's lymphoma more than 5 years after the initial diagnosis is rare. When late relapse occurs, it is difficult to determine whether it is a true recurrence...

... characteristics of cancer stem cells. Methods: We analyzed SP cells from human B-cell non-Hodgkin’s lymphoma cell lines and primary cells derived from patients and compared them with non-SP (NSP) cells. Results: SP cells comprised a minor fraction of all cells ranging from 1.5 ± 1.8 to 8.3 ± 5.7% in cell lines...

...Moritz Stuplich; Karin Mayer; Young Kim; Sharmilan Thanendrarajan; Matthias Simon; Niklas Schäfer; Martin Glas; Ingo G.H. Schmidt-Wolf; Ulrich Herrlinger Richter syndrome (RS) describes the development of high-grade non-Hodgkin’s lymphoma (NHL) from low-grade NHL. RS isolated to the brain is very...

... associated with aplastic anemia or other bone marrow (BM) failure syndromes. We report a previously undescribed case of PNH occurring after autologous stem cell transplantation (ASCT) in a patient affected by relapsing non-Hodgkin’s lymphoma. The intensive chemotherapy and the ASCT resulted in a contraction...

...Jina Yun; Seok Jin Kim; Jung A Kim; Jee Hyun Kong; Soo Hyeon Lee; Kihyun Kim; Young Hyeh Ko; Won Seog Kim Background: The involvement of certain organs such as the adrenal gland and ovaries is rare in non-Hodgkin’s lymphoma (NHL). There are few studies comparing clinical features and prognosis...

...S. Gözdaşoğlu; A.O. Çavdar; A. Arcasoy; N. Akar 40 patients, 15 females and 25 males, with biopsy-proven non-Hodgkin’s lymphoma within the age range of 2–16 years were included in this study. The mean serum zinc level in 38 untreated patients was 78.95 ± 18.80 μ g% and significantly lower than...

..., R.: Immunopathology of follicular lympho­ mas: a model of B lymphocyte homing. New Engl. J. Med. 298: 481-8486 (1978). M. Raphaël Département d'Hématologie CHU Pitié-Salpctricre 47, Boulevard de l Hôpital F-7S013 Paris (France) Lymphocytic malignancies Non-Hodgkin’s lymphoma...

...E. Grau; J. Soler; J. Puig; S. Brunet; N. Pujol-Moix; J.L Rodriguez; A. Domingo-Albós A case with features of both multiple myeloma and non-Hodgkin’s lymphoma at the moment of diagnosis is presented. The patient had lytic bone lesions and biclonal gammopathy, IgM kappa and IgA kappa. In the bone...

...Ahnond Bunyaratvej; Pattraporn Boonkanta; Prawat Nítiyanant; Suntaree Apibal; Natth Bhamarapravati Cell suspension prepared from the lymph node biopsy of patients with non-Hodgkin’s lymphoma (NHL), metastatic carcinoma (MC) and non-neoplastic lymphadenopathies (NL) were analyzed by the Hemalog D...

...E. Pascali; A. Pezzoli 62 consecutive patients with newly diagnosed malignant non-Hodgkin’s lymphoma (NHL) were investigated for the presence, type, and amount of serum and urine monoclonal immunoglobulin abnormalities. The overall incidence of monoclonal gammopathy (MG) was 81%. M components...

...Masao Matsuoka; Norio Asou; Toshio Hattori; Takashi Matsuo; Hiromichí Nishimura; Kiyoshi Takatsuki We report two patients with non-Hodgkin’s lymphoma whose neoplastic cells had rearranged T cell γ chain (T γ ) genes, and had the germ line DNA of T cell receptor β chain (T β) and immunoglobulin...

...Jonathan Abramson; Ram S. Verma A case of an intravenous drug user who, over the course of less than 18 months, was diagnosed as having multiple opportunistic infections, the acquired immunodeficiency syndrome (AIDS) and a non-Hodgkin’s lymphoma is presented. Cytogenetic findings on both bone...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ferritin-secreting cells Non-Hodgkin’s lymphoma Reverse hemolytic plaque assay Acta haemat. 73: 145-149(1985) © 1985...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Composite lymphoma Hodgkin’s disease Lymphoma Non-Hodgkin’s lymphoma Spleen Actahaemat. 76: 29-32(1986) © 1986 S...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Immunohistochemistry Ki-1 antigen Monoclonal antibodies Non-Hodgkin’s lymphoma...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Central nervous system Non-Hodgkin’s lymphoma Spinal cord Spinal nerve roots Acta Haemat 1989;81:44-47 © I 989 S. K a rg er A G , Basel 0001...

...Raymond Liang; Edmond Chiu; Tai-Kwong Chan; David Todd; Shee-Loong Loke The aim of this study was to determine the effect of immunophenotype on the clinical characteristics and prognosis of 144 adult Chinese patients with non-Hodgkin’s lymphomas. Those entities with well-recognised immunophenotype...